Current venous thromboembolism management and outcomes in Japan: Nationwide the Japan venous thromboembolism treatment registry observational study

Circulation Journal

Volumn 78, Issue 3, 2014, Pages 708-717

  Nakamura, Mashio ^a   Miyata, Tetsuro ^e   Ozeki, Yasushi ^c   Takayama, Morimasa ^b   Komori, Kimihiro ^f   Yamada, Norikazu ^a   Origasa, Hideki ^g   Satokawa, Hirono ^h   Maeda, Hideaki ^d   Tanabe, Nobuhiro ⁱ   Unno, Naoki ^j   Shibuya, Takashi ^k   Tanemoto, Kazuo ^f   Kondo, Katsuhiro ^m   Kojima, Tetsuhito ^l  

^a MIE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Development and Medical Affairs Division   (Japan)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e SAKAKIBARA HEART INSTITUTE   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF TOYAMA   (Japan)

^h FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

ⁱ CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^l KAWASAKI MEDICAL SCHOOL   (Japan)

^m KOKURA MEMORIAL HOSPITAL   (Japan)

more..

Author keywords

Deep vein thrombosis; Epidemiology; Pulmonary embolism; Venous thromboembolism

Indexed keywords

HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; JAPAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RECURRENT DISEASE; SURGICAL THROMBECTOMY; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; ACUTE DISEASE; CLINICAL TRIAL; EPIDEMIOLOGY; FIBRINOLYTIC THERAPY; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; MORTALITY; PROCEDURES; RETROSPECTIVE STUDY; VENA CAVA FILTER; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGES; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; VENA CAVA FILTERS; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 84894502096     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0886     Document Type: Article

References (19)

1. JCS Joint Working Group. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009): Digest version. Circ J 2011; 75: 1258-1281.
2. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G; American College of Chest Physicians. Oral anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e44S-e88S, doi:10.1378/ chest.11-2292.
3. Lee CH, Lin LJ, Cheng CL, Kao Yang YH, Chen JY, Tsai LM. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost 2010; 8: 1515-1523.
4. Lee CH, Cheng CL, Lin LJ, Tsai LM, Yang YH. Epidemiology and predictors of short-term mortality in symptomatic venous thromboembolism: A nationwide population-based study. Circ J 2011; 75: 1998-2004.
5. Nakamura M, Fujioka H, Yamada N, Sakuma M, Okada O, Nakanishi N, et al. Clinical characteristics of acute pulmonary thromboembolism in Japan: Results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 2001; 24: 132-138.
6. Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: A randomized trial. Ann Intern Med 2004; 140: 867-873.
7. Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695-1702.
8. Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, et al. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: A randomized trial. JAMA 2005; 293: 681-689.
9. White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
10. Laporte S, Mismetti P, Décousus H, Uresandi F, Otero R, Lobo JL, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716.
11. Arcelus JI, Caprini JA, Monreal M, Suárez C, González-Fajardo J. The management and outcome of acute venous thromboembolism: A prospective registry including 4011 patients. J Vasc Surg 2003; 38: 916-922.
12. Miyahara T, Miyata T, Shigematsu K, Deguchi J, Kimura H, Ishii S, et al. Clinical outcome and complications of temporary inferior vena cava filter placement. J Vasc Surg 2006; 44: 620-624.
13. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e419S-e494S, doi:10.1378/chest.11-2301.
14. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-I8.
15. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med 2000; 160: 761-768.
16. Grau E, Real E, Medrano J, Pastor E, Selfa S. Recurrent venous thromboembolism in a Spanish population: Incidence, risk factors, and management in a hospital setting. Thromb Res 1999; 96: 335-341.
17. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study. Lancet 2003; 362: 523-526.
18. White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96: 267-273.
19. Verso M, Agnelli G, Ageno W, Imberti D, Moia M, Palareti G, et al. Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry. Thromb Res 2012; 130: 369-373.